NEW YORK, Nov. 23 (GenomeWeb News) - Shares in DeCode Genetics were up 5.20 percent at $6.47 in mid-afternoon trading after the company announced plans to jointly develop and market cardiovascular and cerebrovascular drugs with Roche.
...and receive Daily News bulletins.
Already have an account?Login Now.
Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.
The Trump Administration has proposed a plan to reorganize the federal government, the Washington Post reports.
The Economist writes that an increasing number of scientific journals don't do peer review.
In Science this week: genetic overlap among many psychiatric disorders, and more.